aTYR PHARMA (ATYR) Capital Expenditures (2014 - 2026)
aTYR PHARMA's (ATYR) quarterly Capital Expenditures came in at $138000.0 in Q1 2026, up 345.16% on a QoQ basis from $31000.0 in Q4 2025.
aTYR PHARMA (ATYR) Capital Expenditures (2014 - 2026) Analysis & Trends
aTYR PHARMA (ATYR) has 13 years of Capital Expenditures data on file, last reported at $138000.0 in Q1 2026.
- Quarterly Capital Expenditures changed N/A year-over-year to $138000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $215000.0 (up 347.92% YoY) and the FY2025 annual result came in at $77000.0, up 18.46% from the prior year.
- Capital Expenditures improved to $138000.0 in Q1 2026, from $31000.0 in the prior quarter.
- In the past five years, Capital Expenditures ranged from a high of $2.4 million in Q2 2023 to a low of $8000.0 in Q2 2024.
- A 5-year average of $383500.0 and a median of $40000.0 in 2022 frame the typical range for Capital Expenditures.
- Annual changes were most pronounced in 2022 — Capital Expenditures surged 6116.67% — and 2024, when it sank 99.67%.
- Tracing ATYR's Capital Expenditures over 5 years: stood at $1.1 million in 2022, then tumbled by 98.48% to $17000.0 in 2023, then soared by 47.06% to $25000.0 in 2024, then grew by 24.0% to $31000.0 in 2025, then soared by 345.16% to $138000.0 in 2026.
- The last three Capital Expenditures figures came in at $138000.0 (Q1 2026), $31000.0 (Q4 2025), and $37000.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 112.20 Mn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 240.20 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 37.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 25.02 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 34.68 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | -73.57 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 6.26 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 251.02 Mn |
| 10 | aTYR PHARMA | 49.54 Mn | -7.87 Mn | - | 73,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 73,000.00 |
| Jun 30, 2026 | 73,000.00 |
| Mar 31, 2026 | 138,000.00 |
| Mar 31, 2026 | 138,000.00 |
| Dec 31, 2025 | 31,000.00 |
| Dec 31, 2025 | 31,000.00 |
| Sep 30, 2025 | 37,000.00 |
| Sep 30, 2025 | 37,000.00 |
| Jun 30, 2025 | 9,000.00 |
| Jun 30, 2025 | 9,000.00 |
| Dec 31, 2024 | 25,000.00 |
| Dec 31, 2024 | 25,000.00 |
| Sep 30, 2024 | 15,000.00 |
| Sep 30, 2024 | 15,000.00 |
| Jun 30, 2024 | 8,000.00 |
| Jun 30, 2024 | 8,000.00 |
| Mar 31, 2024 | 17,000.00 |
| Mar 31, 2024 | 17,000.00 |
| Dec 31, 2023 | 17,000.00 |
| Dec 31, 2023 | 17,000.00 |